Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 448,269 | 1,492,761 | 19,374,900 | 510,624 | 246,053 |
| Cost of Goods | 181,516 | 684,456 | 1,072,221 | 67,180 | 32,469 |
| Gross Profit | 266,753 | 808,305 | 18,302,680 | 443,444 | 213,584 |
| Operating Expenses | 870,290 | 1,274,828 | 749,647 | 227,980 | 145,491 |
| Operating Income | -603,021 | -466,067 | 17,553,260 | 215,644 | 68,562 |
| Interest Expense | 2,260 | 1,264 | 2,836 | 1,453 | 650 |
| Other Income | 452,247 | 492,569 | 12,616 | 2,426 | 2,908 |
| Pre-tax Income | -153,034 | 25,238 | 17,563,040 | 216,617 | 70,820 |
| Income Tax | 105,321 | -62,893 | 3,104,130 | 31,438 | 5,605 |
| Net Income Continuous | -258,355 | 88,131 | 14,458,910 | 185,179 | 65,215 |
| Minority Interests | -158,437 | -25,735 | 5,991,431 | 74,810 | 20,286 |
| Net Income | $-99,918 | $113,866 | $8,467,480 | $110,369 | $44,929 |
| EPS Basic Total Ops | -1.06 | 1.08 | 85.20 | 1.06 | 0.42 |
| EPS Basic Continuous Ops | -2.59 | 0.89 | 145.59 | 1.87 | 0.69 |
| EPS Diluted Total Ops | -1.06 | 1.00 | 74.27 | 0.97 | 0.41 |
| EPS Diluted Continuous Ops | -2.59 | 0.77 | 126.83 | 1.63 | 0.59 |
| EPS Diluted Before Non-Recurring Items | -1.32 | -0.37 | 74.67 | 1.03 | 0.41 |
| EBITDA(a) | $-460,504 | $-311,219 | $17,637,890 | $219,443 | $73,141 |